Tiago Outeiro, PhD, University Medical Center Göttingen, Göttingen, Germany, highlights the most significant controversies in neurodegenerative diseases, particularly Alzheimer’s disease and Parkinson’s disease. There is an ongoing debate on whether Alzheimer’s disease and Parkinson’s disease should be considered syndromes or diseases instead of single entities. This has potential implications for better understanding disease pathophysiology and the relevance of patient stratification in future clinical trials. The ethical considerations of susceptibility genetic testing for Parkinson’s disease are also an ongoing discussion in the field. This interview took place at the 17th World Congress on Controversies in Neurology (CONy) in Dubrovnik, Croatia.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.